Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 32201 - 32225 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	WARS	7453	upregulated	Cisplatin results in increased expression of WARS mRNA	14q32.2	A20427
Cisplatin	Approved Investigational	WDR70	55100	upregulated	Cisplatin results in increased expression of WDR70 mRNA	5p13.2	A22204
Cisplatin	Approved Investigational	WNT3	7473	upregulated	Cisplatin results in increased expression of WNT3 mRNA	17q21.31-q21.32	A22218
Cisplatin	Approved Investigational	WNT4	54361	upregulated	Cisplatin results in increased expression of WNT4 mRNA	1p36.12	A22218
Cisplatin	Approved Investigational	WWC2	80014	downregulated	Cisplatin results in decreased expression of WWC2 mRNA	4q35.1	A20427
Cisplatin	Approved Investigational	XBP1	7494	downregulated	Cisplatin results in decreased expression of XBP1 mRNA	22q12.1	A20427
Cisplatin	Approved Investigational	XBP1	7494	upregulated	Cisplatin results in increased expression of XBP1 mRNA	22q12.1	A22204
Cisplatin	Approved Investigational	XIAP	331	downregulated	Cisplatin results in decreased expression of XIAP mRNA	Xq25	A22272
Cisplatin	Approved Investigational	XPC	7508	downregulated	Cisplatin results in decreased expression of XPC mRNA	3p25.1	A21499
Cisplatin	Approved Investigational	XPC	7508	upregulated	Cisplatin results in increased expression of XPC mRNA	3p25.1	A22212 A20427
Cisplatin	Approved Investigational	YAP1	10413	downregulated	[Cisplatin results in increased expression of MIR630] which results in decreased expression of YAP1 mRNA	11q22.1	A22223
Cisplatin	Approved Investigational	YARS	8565	downregulated	Cisplatin results in decreased expression of YARS mRNA	1p35.1	A20427
Cisplatin	Approved Investigational	YPEL3	83719	downregulated	Cisplatin results in decreased expression of YPEL3 mRNA	16p11.2	A22204
Cisplatin	Approved Investigational	YTHDC2	64848	downregulated	Cisplatin results in decreased expression of YTHDC2 mRNA	5q22.2	A20427
Cisplatin	Approved Investigational	ZBED1	9189	downregulated	Cisplatin results in decreased expression of ZBED1 mRNA	Xp22.33 and Yp11	A21499
Cisplatin	Approved Investigational	ZBTB24	9841	downregulated	Cisplatin results in decreased expression of ZBTB24 mRNA	6q21	A21499
Cisplatin	Approved Investigational	ZDHHC14	79683	downregulated	Cisplatin results in decreased expression of ZDHHC14 mRNA	6q25.3	A22204
Cisplatin	Approved Investigational	ZFAND2A	90637	upregulated	Cisplatin results in increased expression of ZFAND2A mRNA	7p22.3	A22204
Cisplatin	Approved Investigational	ZFP36L1	677	downregulated	Cisplatin results in decreased expression of ZFP36L1 mRNA	14q24.1	A21499
Cisplatin	Approved Investigational	ZFYVE9	9372	downregulated	Cisplatin results in decreased expression of ZFYVE9 mRNA	1p32.3	A22204
Cisplatin	Approved Investigational	ZIC2	7546	upregulated	Cisplatin results in increased expression of ZIC2 mRNA	13q32.3	A22204
Cisplatin	Approved Investigational	ZMAT3	64393	upregulated	Cisplatin results in increased expression of ZMAT3 mRNA	3q26.32	A22212 A20427
Cisplatin	Approved Investigational	ZMIZ1	57178	downregulated	Cisplatin results in decreased expression of ZMIZ1 mRNA	10q22.3	A22204
Cisplatin	Approved Investigational	ZMYND8	23613	downregulated	Cisplatin results in decreased expression of ZMYND8 mRNA	20q13.12	A22204
Cisplatin	Approved Investigational	ZNF195	7748	upregulated	Cisplatin results in increased expression of ZNF195 mRNA	11p15.5	A22204

Displaying entries 32201 - 32225 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability